Persistent association of nailfold capillaroscopy changes and skin involvement over thirty‐six months with duration of untreated disease in patients with juvenile dermatomyositis
Open Access
- 31 January 2008
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 58 (2) , 571-576
- https://doi.org/10.1002/art.23299
Abstract
Objective To determine the association of changes on nailfold capillaroscopy with clinical findings and genotype in children with juvenile dermatomyositis (DM), in order to identify potential differences in disease course over 36 months. Methods At diagnosis of juvenile DM in 61 children prior to the initiation of treatment, tumor necrosis factor α (TNFα) −308 allele and DQA1*0501 status was determined, juvenile DM Disease Activity Scores (DAS) were obtained, and nailfold capillaroscopy was performed. The disease course was monitored for 36 months. Variations within and between patients were assessed by regression analysis. Results At diagnosis, shorter duration of untreated disease (P = 0.05) and a lower juvenile DM skin DAS (P = 0.035) were associated with a unicyclic disease course. Over 36 months, end‐row loop (ERL) regeneration was associated with lower skin DAS (P < 0.001) but not muscle DAS (P = 0.98); ERL regeneration and decreased bushy loops were associated with a shorter duration of untreated disease (P = 0.04 for both). At 36 months, increased ERL regeneration (P = 0.007) and improvement of skin DAS (P < 0.001) and muscle DAS (P = 0.025) were associated with a unicyclic disease course. Conclusion Early treatment of juvenile DM may lead to a unicyclic disease course. The non‐unicyclic disease course usually involves continuing skin manifestations with persistent nailfold capillaroscopy changes. The correlation of nailfold capillaroscopy results with cutaneous but not with musculoskeletal signs of juvenile DM over a 36‐month period suggests that the cutaneous and muscle vasculopathies have different pathophysiologic mechanisms. These findings indicate that efforts to identify the optimal treatment of cutaneous features in juvenile DM require greater attention.Keywords
This publication has 14 references indexed in Scilit:
- Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositisArthritis Care & Research, 2008
- Immunogenetic risk and protective factors for juvenile dermatomyositis in CaucasiansArthritis & Rheumatism, 2006
- Duration of illness is an important variable for untreated children with juvenile dermatomyositisThe Journal of Pediatrics, 2006
- History of infection before the onset of juvenile dermatomyositis: Results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research RegistryArthritis Care & Research, 2005
- Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops.2004
- Nailfold capillary microscopy in healthy children and in childhood rheumatic diseases: a prospective single blind observational studyAnnals of the Rheumatic Diseases, 2003
- Disease activity score for children with juvenile dermatomyositis: Reliability and validity evidenceArthritis Care & Research, 2003
- Increased Plasma Thrombospondin-1 (TSP-1) Levels Are Associated with the TNFα-308A Allele in Children with Juvenile DermatomyositisClinical Immunology, 2002
- Lack of detection of enteroviral rna or bacterial dna in magnetic resonance imaging–directed muscle biopsies from twenty children with active untreated juvenile dermatomyositisArthritis & Rheumatism, 1995
- Polymyositis and DermatomyositisNew England Journal of Medicine, 1975